메뉴 건너뛰기




Volumn 100, Issue 1, 2015, Pages 55-62

Clinical and molecular features of hürthle cell carcinoma of the thyroid

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RADIOACTIVE IODINE; TELOMERASE REVERSE TRANSCRIPTASE; THYROGLOBULIN; TELOMERASE; TERT PROTEIN, HUMAN;

EID: 84920578992     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1634     Document Type: Article
Times cited : (96)

References (31)
  • 1
    • 70449370231 scopus 로고    scopus 로고
    • Revised american thyroid association manage ment guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • American Thyroid Association (ATA Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer
    • American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association manage ment guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
    • (2009) Thyroid , vol.19 , pp. 1167-1214
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3
  • 3
    • 59649108225 scopus 로고    scopus 로고
    • Hürthle cell carcinoma of the thyroid: Ret rospective review of 62 patients treated at the royal marsden hospital between 1946 and 2003
    • Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: ret rospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009; 35:230-234.
    • (2009) Eur J Surg Oncol , vol.35 , pp. 230-234
    • Mills, S.C.1    Haq, M.2    Smellie, W.J.3    Harmer, C.4
  • 4
    • 0030442842 scopus 로고    scopus 로고
    • Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid
    • Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg. 1996;172:692-694.
    • (1996) Am J Surg , vol.172 , pp. 692-694
    • Shaha, A.R.1    Shah, J.P.2    Loree, T.R.3
  • 5
    • 84863453704 scopus 로고    scopus 로고
    • Histological patterns of locoregional recurrence in hürthle cell carcinoma of the thyroid gland
    • Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid. 2012;22:690-694.
    • (2012) Thyroid , vol.22 , pp. 690-694
    • Bishop, J.A.1    Wu, G.2    Tufano, R.P.3    Westra, W.H.4
  • 6
    • 40949154349 scopus 로고    scopus 로고
    • Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with hürthle cell or follicular thyroid cancer
    • Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hürthle cell or follicular thyroid cancer. Am J Surg. 2008;195:457-462.
    • (2008) Am J Surg , vol.195 , pp. 457-462
    • Kushchayeva, Y.1    Duh, Q.Y.2    Kebebew, E.3    D'Avanzo, A.4    Clark, O.H.5
  • 7
    • 0032587215 scopus 로고    scopus 로고
    • Hürthle cell carcinoma: A malignancy of low-grade potential
    • Khafif A, Khafif RA, Attie JN. Hürthle cell carcinoma: a malignancy of low-grade potential. Head Neck. 1999;21:506-511.
    • (1999) Head Neck , vol.21 , pp. 506-511
    • Khafif, A.1    Khafif, R.A.2    Attie, J.N.3
  • 8
    • 0037319864 scopus 로고    scopus 로고
    • Survival and prognosis in hürthle cell carcinoma of the thyroid gland
    • Bhattacharyya N. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003;129: 207-210.
    • (2003) Arch Otolaryngol Head Neck Surg , vol.129 , pp. 207-210
    • Bhattacharyya, N.1
  • 9
    • 29144508427 scopus 로고    scopus 로고
    • The treatment and prognosis of hürthle cell follicular thyroid carcinoma compared with its non-hürthle cell counterpart
    • discussion 1157-1158
    • Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery. 2005;138:1152-1157; discussion 1157-1158.
    • (2005) Surgery , vol.138 , pp. 1152-1157
    • Haigh, P.I.1    Urbach, D.R.2
  • 10
    • 84888010592 scopus 로고    scopus 로고
    • Hurthle cell carcinoma: An update on survival over the last 35 years
    • discussion 1271
    • Nagar S, Aschebrook-Kilfoy B, Kaplan EL, Angelos P, Grogan RH. Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery. 2013;154:1263-1271; discussion 1271.
    • (2013) Surgery , vol.154 , pp. 1263-1271
    • Nagar, S.1    Aschebrook-Kilfoy, B.2    Kaplan, E.L.3    Angelos, P.4    Grogan, R.H.5
  • 11
    • 84872912002 scopus 로고    scopus 로고
    • Hürthle cell carcinoma: A population-level analysis of 3311 patients
    • Goffredo P, Roman SA, Sosa JA. Hürthle cell carcinoma: a population-level analysis of 3311 patients. Cancer. 2013;119:504-511.
    • (2013) Cancer , vol.119 , pp. 504-511
    • Goffredo, P.1    Roman, S.A.2    Sosa, J.A.3
  • 12
    • 84877710820 scopus 로고    scopus 로고
    • Genomic dissection of hürthle cell carcinoma reveals a unique class of thyroid malignancy
    • Ganly I, Ricarte Filho J, Eng S, et al. Genomic dissection of Hürthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98:E962-E972.
    • (2013) J Clin Endocrinol Metab , vol.98 , pp. E962-E972
    • Ganly, I.1    Ricarte Filho, J.2    Eng, S.3
  • 15
    • 84874191269 scopus 로고    scopus 로고
    • Tert promoter mutations in familial and sporadic melanoma
    • Horn S, Fi gl A, Rachakonda PS, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339:959-961.
    • (2013) Science , vol.339 , pp. 959-961
    • Horn, S.1    Figl, A.2    Rachakonda, P.S.3
  • 16
    • 84883711485 scopus 로고    scopus 로고
    • Frequent somatic tert promote r mutations in thyroid cancer: Higher prevalence in advanced forms of the disease
    • Landa I, Ganly I, Chan TA, et al. Frequent somatic TERT promote r mutations in thyroid cancer: higher prevalence in advanced forms of the disease. J Clin Endocrinol Metab. 2013;98:E1562-E1566.
    • (2013) J Clin Endocrinol Metab , vol.98 , pp. E1562-E1566
    • Landa, I.1    Ganly, I.2    Chan, T.A.3
  • 17
    • 84899908886 scopus 로고    scopus 로고
    • Tert promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    • Melo M, da Rocha AG, Vinagre J, et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2014;99:E754-E765.
    • (2014) J Clin Endocrinol Metab , vol.99 , pp. E754-E765
    • Melo, M.1    Da Rocha, A.G.2    Vinagre, J.3
  • 18
    • 84908556575 scopus 로고    scopus 로고
    • Tert promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (fta) and atypical fta
    • Wang N, Liu T, Sofiadis A, et al. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. Cancer 2014;120:2965-2979.
    • (2014) Cancer , vol.120 , pp. 2965-2979
    • Wang, N.1    Liu, T.2    Sofiadis, A.3
  • 19
    • 0036209886 scopus 로고    scopus 로고
    • Hürthle cell carcinoma: A 60-year experience
    • Stojadinovic A, Hoos A, Ghossein RA, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002;9:197-203.
    • (2002) Ann Surg Oncol , vol.9 , pp. 197-203
    • Stojadinovic, A.1    Hoos, A.2    Ghossein, R.A.3
  • 21
    • 0037369140 scopus 로고    scopus 로고
    • Prognostic factors in patients with hürthle cell neoplasms of the thyroid
    • Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 2003; 97:1186-1194.
    • (2003) Cancer , vol.97 , pp. 1186-1194
    • Lopez-Penabad, L.1    Chiu, A.C.2    Hoff, A.O.3
  • 22
    • 0035873951 scopus 로고    scopus 로고
    • Hürthle cell carcinoma: A critical histopathologic appraisal
    • Stojadinovic A, Ghossein RA, Hoos A, et al. Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 2001;19:2616-2625.
    • (2001) J Clin Oncol , vol.19 , pp. 2616-2625
    • Stojadinovic, A.1    Ghossein, R.A.2    Hoos, A.3
  • 23
    • 33646056429 scopus 로고    scopus 로고
    • Prognostic factors of recurrence in encapsulated hürthle cell carcinoma of the thyroid gland: A clinicopathologic study of 50 cases
    • Ghossein RA, Hiltzik DH, Carlson DL, et al. Prognostic factors of recurrence in encapsulated Hürthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006;106 : 1669-1676.
    • (2006) Cancer , vol.106 , pp. 1669-1676
    • Ghossein, R.A.1    Hiltzik, D.H.2    Carlson, D.L.3
  • 24
    • 0033952494 scopus 로고    scopus 로고
    • Metastatic minimally invasive (encapsulated) follicular and hürthle cell thyroid carcinoma: A study of 34 patients
    • Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hürthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2000;13:123-13 0.
    • (2000) Mod Pathol , vol.13 , pp. 123-130
    • Goldstein, N.S.1    Czako, P.2    Neill, J.S.3
  • 25
    • 33744535887 scopus 로고    scopus 로고
    • Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer
    • Lind P, Kohlfürst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36:194-205.
    • (2006) Semin Nucl Med , vol.36 , pp. 194-205
    • Lind, P.1    Kohlfürst, S.2
  • 26
    • 79251482826 scopus 로고    scopus 로고
    • Thyroid cancer-indications and opportunities for positron emission tomography/computed tomography imaging
    • Abraham T, Schöder H. Thyroid cancer-indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med. 2011;41:121-138.
    • (2011) Semin Nucl Med , vol.41 , pp. 121-138
    • Abraham, T.1    Schöder, H.2
  • 27
    • 0022627413 scopus 로고
    • Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy
    • Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hürthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer. 1986;57:1613-1617.
    • (1986) Cancer , vol.57 , pp. 1613-1617
    • Har-El, G.1    Hadar, T.2    Segal, K.3    Levy, R.4    Sidi, J.5
  • 28
    • 84864711852 scopus 로고    scopus 로고
    • Postradioio dine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels
    • Leboulleux S, El Bez I, Borget I, et al. Postradioio dine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels. Thyroid. 2012;22:832-838.
    • (2012) Thyroid , vol.22 , pp. 832-838
    • Leboulleux, S.1    El Bez, I.2    Borget, I.3
  • 29
    • 84872349927 scopus 로고    scopus 로고
    • The role of 18f-fluorodeoxyglucose positron emission tomography in the prognostication, diagnosis, and management of thyroid carcinoma
    • Lang B H. The role of 18F-fluorodeoxyglucose positron emission tomography in the prognostication, diagnosis, and management of thyroid carcinoma. J Thyroid Res. 2012;2012:198313.
    • (2012) J Thyroid Res , vol.2012 , pp. 198313
    • Lang, B.H.1
  • 30
    • 33749046302 scopus 로고    scopus 로고
    • Diagnostic accuracy and prognostic value of 18f-fdg pet in hürthle cell thyroid cancer patients
    • Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med. 2006;47:1260-1266.
    • (2006) J Nucl Med , vol.47 , pp. 1260-1266
    • Pryma, D.A.1    Schöder, H.2    Gönen, M.3    Robbins, R.J.4    Larson, S.M.5    Yeung, H.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.